Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. [electronic resource]
Producer: 20080108Description: 1448-54 p. digitalISSN:- 1083-8791
- Adult
- Aged
- Busulfan -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hepatic Veno-Occlusive Disease -- chemically induced
- Humans
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- therapy
- Myeloablative Agonists -- administration & dosage
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Spain
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.